Last $15.67 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 4:30 PM 12/8/13 All times are local (Market data is delayed by at least 15 minutes).

calian technologies ltd (CLNFF) Key Developments

Calian Technologies Ltd. Announces Management Changes, Effective March 31, 2015

Calian Technologies Ltd. announced that Ray Basler, its President and CEO, has decided to retire effective March 31, 2015. The Board of Directors has unanimously appointed Kevin Ford, leader of the Company's BTS division, to take on the position of President and CEO upon completion of the transition period on March 31, 2015.

Calian Technologies Ltd. Declares a Quarterly Dividend, Payable on December 10, 2014

Calian Technologies Ltd. declared a quarterly dividend of $0.28 per share. The dividend is payable December 10, 2014 to shareholders of record as of November 26, 2014. Dividends paid by the corporation are considered "eligible dividend" for tax purposes.

Calian Technologies Ltd. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2014; Provides Earnings Guidance for the Year 2015

Calian Technologies Ltd. announced unaudited consolidated earnings results for the fourth quarter and full year ended September 30, 2014. For the quarter, the company reported revenues were $54.4 million, a 5% decrease from the $57.5 million reported in the same quarter of the previous year. Net profit was $2.6 million or $0.35 per basic and diluted share, compared to $3.0 million or $0.41 per basic and diluted share in the same quarter of the previous year. Adjusted net profit was $2.8 million or $0.38 per basic and diluted share, compared to $3.0 million or $0.41 per basic and diluted share in the same quarter of the previous year. Profit before interest income and income tax expense was $3,600,000 compared to $4,070,000 for the same period a year ago. Profit before income tax expense was $3,657,000 compared to $4,155,000 for the same period a year ago. EBITDA was $4,525,000 compared to $4,487,000 for the same period a year ago. For the year, the company reported revenues were $211.3 million compared to revenues of $232.0 million in the prior year. Net profit was $10.6 million or $1.44 per basic and diluted share compared to net profit of $13.1 million or $1.73 per basic and diluted share in the previous year. Adjusted net profit was $10.7 million or $1.45 per share basic and diluted compared to net profit of $13.1 million or $1.73 per share basic and diluted in the previous year. Profit before interest income and income tax expense was $14,116,000 compared to $17,444,000 for the same period a year ago. Profit before income tax expense was $14,387,000 compared to $17,796,000 for the same period a year ago. Cash flows from operating activities were $11,438,000 compared to $12,533,000 for the same period a year ago. Equipment and application software expenditures were $1,188,000 compared to $725,000 for the same period a year ago. EBITDA was $16,216 compared to EBITDA of $19,083 in the previous year. The company provided earnings guidance for the year 2015. The company expected revenues for fiscal 2015 to be in the range of $235 million to $265 million, net profit per share in the range of $1.35 to $1.65 per share and adjusted net profit in the range of $1.50 to $1.80 per share.

Calian Technologies Ltd., Q4 2014 Earnings Call, Nov 12, 2014

Calian Technologies Ltd., Q4 2014 Earnings Call, Nov 12, 2014

Calian Technologies Ltd. Announces Management Appointments

Calian Technologies Ltd. announced that Scott Murray has joined Calian's BTS division as Vice President for Health Services. In this position, Scott will be responsible for the delivery and growth of Calian's Health Services portfolio. Scott has over 20 years of experience in healthcare and brings to Calian a background in corporate strategy, business development, pharmacy and law. Previously, Scott served as Director of Partnerships with Theranos Inc. Dr. Michael Eden-Walker will serve as Calian's Medical Director. This position will be primarily responsible for monitoring the quality of health services and evaluating the overall patient experience. As Medical Director, Dr. Eden-Walker will help Calian establish and implement policies and procedures governing standards of care and best practices and will provide ongoing professional guidance and oversight to ensure patient safety and the consistent delivery of the highest quality of care. Dr. Hans Jung has agreed to serve as a Medical Advisor to Calian.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLNFF:US $15.67 USD 0.00

CLNFF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alcatel-Lucent €3.11 EUR -0.01
CGI Group Inc C$48.25 CAD -0.05
General Dynamics Corp $139.85 USD -1.47
ManpowerGroup Inc $66.96 USD -0.71
View Industry Companies
 

Industry Analysis

CLNFF

Industry Average

Valuation CLNFF Industry Range
Price/Earnings 11.7x
Price/Sales 0.6x
Price/Book 1.8x
Price/Cash Flow 9.8x
TEV/Sales 0.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CALIAN TECHNOLOGIES LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.